Literature DB >> 23991369

The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Julia I-Ju Leu1, Maureen E Murphy, Donna L George.   

Abstract

The p53 protein is a critical stress-response mediator and signal coordinator in cellular metabolism and environmental exposure to deleterious agents. In human populations, the p53 gene contains a common single nucleotide polymorphism (SNP) affecting codon 72 that determines whether a proline (P72) or an arginine (R72) is present at this amino acid position of the polypeptide. Previous studies carried out using human populations, mouse models, and cell culture analyses have provided evidence that this amino acid difference can alter p53 functional activities, and potentially also can affect clinical presentation of disease. The clinical presentation associated with many forms of liver disease is variable, but few of the responsible underlying genetic factors or molecular pathways have been identified. The aim of the present study was to investigate whether the p53 codon 72 polymorphism influences the cellular response to hepatic stresses. A humanized p53 knock-in (Hupki) mouse model was used to address this issue. Mice expressing either the P72 or R72 normal variation of p53 were given an acute-, intermittent- or a chronic challenge, associated with exposure to lipopolysaccharide, D-galactosamine, or a high-fat diet. The results reveal that the livers of the P72 and R72 mice exhibit notable differences in inflammatory and apoptotic response to these distinct forms of stress. Interestingly the influence of this polymorphism on the response to stress is context dependent, with P72 showing increased response to liver toxins (lipopolysaccharide and D-galactosamine), but R72 showing increased response to metabolic stress (high fat diet). When taken together, these data point to the p53 codon 72 polymorphism as an important molecular mediator of events contributing to hepatic inflammation and metabolic homeostasis.

Entities:  

Keywords:  Apoptosis; Gene polymorphism; Hepatic inflammation; Hupki; Liver; p53 codon 72 polymorphism

Year:  2013        PMID: 23991369      PMCID: PMC3753047          DOI: 10.4172/2167-0889.1000117

Source DB:  PubMed          Journal:  J Liver        ISSN: 2167-0889


  68 in total

1.  Variation in the care of septic shock: the impact of patient and hospital characteristics.

Authors:  Tara Lagu; Michael B Rothberg; Brian H Nathanson; Penelope S Pekow; Jay S Steingrub; Peter K Lindenauer
Journal:  J Crit Care       Date:  2012-02-01       Impact factor: 3.425

Review 2.  Polymorphic variants in the p53 pathway.

Authors:  M E Murphy
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

3.  Two polymorphic variants of wild-type p53 differ biochemically and biologically.

Authors:  M Thomas; A Kalita; S Labrecque; D Pim; L Banks; G Matlashewski
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  R72P polymorphism of TP53 in ulcerative colitis patients is associated with the incidence of colectomy, use of steroids and the presence of a positive family history.

Authors:  Fatih Eren; Mustafa Akkiprik; Ozlen Atuğ; Ozgür Sönmez; Gülgün Tahan; Filiz Ozdemir; Hülya Over Hamzaoğlu; Ciğdem Ataizi Celikel; Neşe Imeryüz; Erol Avşar; Ayşe Ozer
Journal:  Pathol Oncol Res       Date:  2010-03-23       Impact factor: 3.201

5.  Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.

Authors:  Sacha Brigitte Geutskens; Françoise Homo-Delarche; Jean-Marie Pleau; Sylvie Durant; Hemmo Arjan Drexhage; Wilson Savino
Journal:  Cell Tissue Res       Date:  2004-10-05       Impact factor: 5.249

Review 6.  D-galactosamine lethality model: scope and limitations.

Authors:  Richard Silverstein
Journal:  J Endotoxin Res       Date:  2004

7.  Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Authors:  Akinori Takaoka; Sumio Hayakawa; Hideyuki Yanai; Dagmar Stoiber; Hideo Negishi; Hideaki Kikuchi; Shigeru Sasaki; Kohzoh Imai; Tsukasa Shibue; Kenya Honda; Tadatsugu Taniguchi
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

8.  Role of MCP-1 in endotoxemia and sepsis.

Authors:  Raina Devi Ramnath; Siaw Wei Ng; Angelo Guglielmotti; Madhav Bhatia
Journal:  Int Immunopharmacol       Date:  2008-03-18       Impact factor: 4.932

Review 9.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

10.  Transcriptional role of p53 in interferon-mediated antiviral immunity.

Authors:  César Muñoz-Fontela; Salvador Macip; Luis Martínez-Sobrido; Lauren Brown; Joseph Ashour; Adolfo García-Sastre; Sam W Lee; Stuart A Aaronson
Journal:  J Exp Med       Date:  2008-07-28       Impact factor: 14.307

View more
  6 in total

1.  The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.

Authors:  Che-Pei Kung; Qin Liu; Maureen E Murphy
Journal:  Cancer Biol Ther       Date:  2017-05-05       Impact factor: 4.742

2.  Association of p53 codon 72 polymorphism with susceptibility to hepatocellular carcinoma in a Chinese population from northeast Sichuan.

Authors:  Jiajing Cai; Yan Cai; Qiang Ma; Fan Chang; Lei Xu; Guoyuan Zhang; Xiaolan Guo
Journal:  Biomed Rep       Date:  2017-01-11

Review 3.  p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics).

Authors:  Daniela Milani; Lorenzo Caruso; Enrico Zauli; Adi Mohammed Al Owaifeer; Paola Secchiero; Giorgio Zauli; Donato Gemmati; Veronica Tisato
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

4.  Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors.

Authors:  Laura Di Renzo; Santo Gratteri; Francesca Sarlo; Andrea Cabibbo; Carmen Colica; Antonino De Lorenzo
Journal:  Dis Markers       Date:  2014-10-13       Impact factor: 3.434

Review 5.  Regulators of Oncogenic Mutant TP53 Gain of Function.

Authors:  Satomi Yamamoto; Tomoo Iwakuma
Journal:  Cancers (Basel)       Date:  2018-12-20       Impact factor: 6.639

6.  A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models.

Authors:  Yuhan Zhao; Lihua Wu; Xuetian Yue; Cen Zhang; Jianming Wang; Jun Li; Xiaohui Sun; Yiming Zhu; Zhaohui Feng; Wenwei Hu
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.